Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Instem Plc LSE:INS London Ordinary Share GB00B3TQCK30 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 685.00 680.00 690.00 685.00 685.00 685.00 0.00 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 25.7 -0.9 -5.7 - 143

Instem Share Discussion Threads

Showing 826 to 840 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
28/2/2013
08:25
I just sold out at 137 - profit is a profit but am sure will be kicking myself later :)
parvez
28/2/2013
08:15
will it top around 170p today as no stoc available!?
parvez
28/2/2013
07:32
Very interesting company Strong balance sheet with cash of around £2.8m and signing contracts like there's no tomorrow plus this from early Feb this year Mike Harwood, Instem's Senior Vice President, comments, "Client feedback throughout this development project has been extremely positive and has helped to ensure that version 9 is a robust, high quality, fit-for-purpose application for the Tox/Path market. The features included in version 9 are in high demand; numerous clients have committed to upgrading with several more poised to sign shortly." http://www.cnbc.com/id/100442617/Instem_Releases_Version_9_of_Provantis
mirabeau
09/1/2012
22:07
profeet warning
dugganjoe
24/3/2011
10:54
http://www.growthcompany.co.uk/news/1612938/asia-helps-instem-profits.thtml Rating and comment on the shares
ibrahim1962
19/1/2011
22:17
Trading statement today looks positive. Quiet here also a positive.
choppa
17/1/2011
11:04
An intriguing play added today.
choppa
15/10/2010
15:18
some buying now up 5%
andrbea
13/10/2010
10:22
what we got here then andrbea ? ;-)
jab118
13/10/2010
08:54
COMMENCEMENT OF DEALING IN SHARES Instem Life Science Systems plc (AIM:INS.L), a leading provider of IT applications to the global early development healthcare market, is pleased to announce that dealings will commence today in its Ordinary Shares following its admission to AIM, under the ticker INS. Instem has raised £9.15 million (prior to expenses) through a placing by Brewin Dolphin of 5,228,376 new Ordinary Shares at the placing price of 175p per share. Following the placing, there will be 11,714,286 Ordinary Shares in issue, giving Instem a market capitalisation of £20.50 million at the placing price. The percentage of Ordinary Shares in public hands on Admission will be approximately 45 per cent. Based in Staffordshire, Instem is the leading provider of Early Development Safety Assessment software, providing its services to over 80 customers, including seven of the top ten global pharmaceutical and biotech companies. The Company has in place a reputable and established business, primarily in North America, Europe and the UK, and expects to grow organically, and where appropriate, acquisitively to accelerate its growth trajectory. General market drivers such as increased R&D productivity requirements, increasing regulatory pressure, growing Far Eastern markets and the ongoing trend to outsource are expected to drive increased demand for Instem's solutions. Phil Reason, CEO of Instem Life Science Systems plc, commented, "We have been delighted with the response from investors and believe AIM will provide us with an excellent platform as we seek to further our market leading position through both organic and acquisitive growth."
andrbea
13/10/2010
08:48
New float LONDON -(Dow Jones)- Healthcare IT company Instem Life Science Systems PLC said Monday it is to raise GBP9.15 million in an initial public offering on London's junior Alternative Investment Market. Instem, which makes management software used by drug makers like GlaxoSmithKline PLC (GSK.LN), said it intends to use the money raised to pay for acquisitions, launch new products and boost its presence in Japan and China. The company said dealings in its shares are expected to start on Oct. 13. Brewin Dolphin is the company's nominated adviser and broker. Instem said it expects to have a market capitalization on admission of GBP20.5 million.
andrbea
05/1/2010
16:26
free stock charts from www.advfn.com
jamdon2
17/11/2007
22:13
i would not sell my few.
valter
29/7/2007
10:28
i think they have to keep the offer open, or up it.
valter
28/7/2007
13:48
No they have a majority now. They could actually drop the offer, but they probably will keep it level. My advice is to get rid of them now before you get stuck with dead shares that you can only redeem via the registrar. DYOR etc.
joestalin
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
ADVFN Advertorial
Your Recent History
LSE
INS
Instem
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210506 10:36:24